SEC Form 4 · accession 0001493152-26-035212
OKYO Pharma Ltd · OKYO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Rajkumar V. Patil
Officer — Chief Scientific Officer
Period of report
Jul 27, 2026
Accepted (ET)
Jul 29, 2026 · 4:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001849296
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 27, 2026 | A | 3,363 | $1.49 | A | 20,030 | D |
Table II — derivative securities
No Table II lines on this filing.